blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2205737

EP2205737 - MICROMIRS [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  24.12.2021
Database last updated on 03.04.2025
Most recent event   Tooltip24.12.2021Revocation of patentpublished on 26.01.2022  [2022/04]
24.12.2021New entry: Despatch of communication that patent is revoked 
Applicant(s)For all designated states
Roche Innovation Center Copenhagen A/S
Fremtidsvej 3
2970 Hørsholm / DK
[2015/01]
Former [2013/03]For all designated states
Santaris Pharma A/S
Fremtidsvej 3
2970 Hørsholm / DK
Former [2010/28]For all designated states
Santaris Pharma A/S
Kogle Allé 6
2970 Hørsholm / DK
Inventor(s)01 / OBAD, Susanna
Nicoloviusgatan 10 A
S-217 57 Malmö / SE
02 / KAUPPINEN, Sakari
Norskekrogen 12
DK-2765 Smørum / DK
03 / ELMÉN, Joacim
Sickla Kanalgata 19A
S-120 67 Stockholm / SE
04 / LINDOW, Morten
Thomas Koppels Allé 22C
DK-2450 Copenhagen SV / DK
05 / HEIDENBLAD, Markus
Mantalskroken 9
S-226 47 Lund / SE
 [2011/40]
Former [2010/28]01 / OBAD, Susanna
Roslins Väg 18D
S-217 55 Malmo / SE
02 / KAUPPINEN, Sakari
Norskekrogen 12
DK-2765 Smørum / DK
03 / ELMEN, Joacim
Föreningsgaten 61
S-211 52 Malmö / SE
04 / LINDOW, Morten
Thomas Koppels Allé 22C
DK-2450 Copenhagen SV / DK
05 / HEIDENBLAD, Markus
Mantalskroken 9
S-226 47 Lund / SE
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2013/33]Turner, Mark Frederic Paris, et al
Santaris Pharma A/S
Fremtidsvej 3
2970 Hørsholm / DK
Former [2013/07]Turner, Mark Frederic Paris
Santaris Pharma A/S Bøge Allé 3-5
2970 Hørsholm / DK
Former [2010/28]Turner, Mark Frederic Paris
Santaris Pharma A/S Bøge Allé 3-5
2970 Hørsholm / DK
Application number, filing date08801378.403.10.2008
[2010/28]
WO2008DK00344
Priority number, dateUS20070977497P04.10.2007         Original published format: US 977497 P
US20070979217P11.10.2007         Original published format: US 979217 P
US2008002806212.02.2008         Original published format: US 28062
EP2008010478017.07.2008         Original published format: EP 08104780
[2010/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009043353
Date:09.04.2009
Language:EN
[2009/15]
Type: A2 Application without search report 
No.:EP2205737
Date:14.07.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 09.04.2009 takes the place of the publication of the European patent application.
[2010/28]
Type: B1 Patent specification 
No.:EP2205737
Date:13.02.2013
Language:EN
[2013/07]
Search report(s)International search report - published on:EP20.08.2009
ClassificationIPC:C12N15/113
[2012/24]
CPC:
C12N15/113 (EP,US); A61K31/713 (EP,US); A61K45/06 (US);
A61P3/06 (EP); A61P31/14 (EP); A61P43/00 (EP);
C12N15/111 (EP,US); C12N15/1131 (EP,US); C12N2310/113 (EP,US);
C12N2310/14 (EP,US); C12N2310/141 (EP,US); C12N2310/315 (EP,US);
C12N2310/32 (EP,US); C12N2310/321 (EP,US); C12N2310/322 (EP,US);
C12N2310/3231 (EP,US); C12N2310/3341 (EP,US); C12N2310/34 (EP,US);
C12N2310/351 (EP,US); C12N2310/3513 (EP,US); C12N2310/3525 (EP,US);
C12N2310/3533 (EP,US); C12N2320/31 (EP,US); Y02A50/30 (EP,US) (-)
Former IPC [2010/28]C12N15/11, A61K31/7105, A61K31/7115, A61K31/712
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/28]
Extension statesALNot yet paid
BANot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:MIKROMIR-MOLEKÜLE[2010/28]
English:MICROMIRS[2010/28]
French:OLIGONUCLÉOTIDES MICROMIR[2010/28]
Entry into regional phase28.04.2010National basic fee paid 
28.04.2010Designation fee(s) paid 
28.04.2010Examination fee paid 
Examination procedure28.04.2010Amendment by applicant (claims and/or description)
28.04.2010Examination requested  [2010/28]
02.11.2010Despatch of a communication from the examining division (Time limit: M04)
10.03.2011Reply to a communication from the examining division
28.10.2011Despatch of a communication from the examining division (Time limit: M04)
18.11.2011Reply to a communication from the examining division
23.07.2012Communication of intention to grant the patent
28.09.2012Fee for grant paid
28.09.2012Fee for publishing/printing paid
Divisional application(s)EP12191738.9  / EP2623598
EP12191739.7  / EP2623599
EP18185844.0  / EP3492594
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.11.2010
Opposition(s)Opponent(s)01  12.11.2013  10.02.2014  ADMISSIBLE
Mirx Therapeutics A/S/Querdenker ApS
Dandyvej 19 /
Skovvænget 32
7100 Vejle / 5792 Aarslev / DK
Opponent's representative
Orsnes, Henrik Egede
Orsnes Patent
Sentvedvej 23
5853 Oerbaek / DK
 02  13.11.2013  10.02.2014  ADMISSIBLE
Exiqon A/S
Skelstedet 16
2950 Vedbaek / DK
Opponent's representative
Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
 03  13.11.2013  10.02.2014  ADMISSIBLE
Chapman, Desmond Mark
Carpmaels & Ransford
One Southampton Row
London WC1B 5HA / GB
Opponent's representative
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
 [N/P]
Former [2021/37]
Opponent(s)01  12.11.2013  10.02.2014  ADMISSIBLE
Mirx Therapeutics A/S/Querdenker ApS
Dandyvej 19 /
Skovvænget 32
7100 Vejle / 5792 Aarslev / DK
Opponent's representative
Orsnes, Henrik Egede
Orsnes Patent
Forskerparken 10
5230 Odense M / DK
 02  13.11.2013  10.02.2014  ADMISSIBLE
Exiqon A/S
Skelstedet 16
2950 Vedbaek / DK
Opponent's representative
Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
 03  13.11.2013  10.02.2014  ADMISSIBLE
Chapman, Desmond Mark
Carpmaels & Ransford
One Southampton Row
London WC1B 5HA / GB
Opponent's representative
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Former [2014/01]
Opponent(s)01  12.11.2013    ADMISSIBLE
Mirx Therapeutics A/S/Querdenker ApS
Dandyvej 19 /
Skovvænget 32
7100 Vejle / 5792 Aarslev / DK
Opponent's representative
Orsnes, Henrik Egede
Orsnes Patent Forskerparken 10
5230 Odense M / DK
 02  13.11.2013    ADMISSIBLE
Exiqon A/S
Skelstedet 16
2950 Vedbaek / DK
Opponent's representative
Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
 03  13.11.2013    ADMISSIBLE
Chapman, Desmond Mark
Carpmaels & Ransford
One Southampton Row
London WC1B 5HA / GB
Opponent's representative
Chapman, Desmond Mark
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
13.02.2014Invitation to proprietor to file observations on the notice of opposition
12.08.2014Reply of patent proprietor to notice(s) of opposition
31.10.2014Cancellation of oral proceeding that was planned for 12.03.2015
12.03.2015Date of oral proceedings
01.12.2015Date of oral proceedings
04.01.2016Despatch of a communication from the opposition division (Time limit: M01)
04.01.2016Despatch of minutes of oral proceedings
04.02.2016Reply to a communication from the opposition division
17.03.2016Despatch of interlocutory decision in opposition
15.11.2021Legal effect of revocation of patent [2022/04]
18.11.2021Despatch of communication that the patent will be revoked
Appeal following opposition27.05.2016Appeal received No.  T1302/16
27.07.2016Statement of grounds filed
15.11.2021Result of appeal procedure: revocation of the patent
18.11.2021Despatch of the decision of the Board of Appeal
Fees paidRenewal fee
25.10.2010Renewal fee patent year 03
25.10.2011Renewal fee patent year 04
25.10.2012Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.10.2008
CY13.02.2013
CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
MT13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
LU03.10.2013
AT03.10.2017
FI03.10.2017
IE03.10.2017
SE04.10.2017
BE31.10.2017
NL01.11.2017
[2018/45]
Former [2018/39]HU03.10.2008
CY13.02.2013
CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
MT13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
LU03.10.2013
AT03.10.2017
FI03.10.2017
SE04.10.2017
BE31.10.2017
NL01.11.2017
Former [2018/36]HU03.10.2008
CY13.02.2013
CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
MT13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
LU03.10.2013
FI03.10.2017
BE31.10.2017
NL01.11.2017
Former [2015/41]HU03.10.2008
CY13.02.2013
CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
MT13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
LU03.10.2013
Former [2015/34]HU03.10.2008
CY13.02.2013
CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
LU03.10.2013
Former [2015/32]CY13.02.2013
CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
TR13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2015/30]CY13.02.2013
CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2014/25]CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
MC13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/49]CZ13.02.2013
EE13.02.2013
HR13.02.2013
LT13.02.2013
LV13.02.2013
PL13.02.2013
RO13.02.2013
SI13.02.2013
SK13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/41]HR13.02.2013
LT13.02.2013
LV13.02.2013
PL13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/40]LT13.02.2013
LV13.02.2013
PL13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
PT13.06.2013
Former [2013/38]LT13.02.2013
LV13.02.2013
PL13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
Former [2013/37]LT13.02.2013
PL13.02.2013
SI13.02.2013
BG13.05.2013
NO13.05.2013
GR14.05.2013
IS13.06.2013
Former [2013/36]LT13.02.2013
PL13.02.2013
BG13.05.2013
NO13.05.2013
IS13.06.2013
Former [2013/34]LT13.02.2013
BG13.05.2013
NO13.05.2013
IS13.06.2013
Former [2013/33]LT13.02.2013
NO13.05.2013
Cited inInternational search[PA]WO2007112753  (SANTARIS PHARMA AS [DK], et al);
ExaminationWO2008061537
by applicantUS4914210
 US4962029
 WO9914226
 WO0056746
 WO0056748
 WO0125248
 WO0228875
 WO03006475
 WO03095467
 WO2005098029
 WO2006069584
 US7087229
 WO2007112754
 WO2007112753
 US2008034122
 WO2008034123
 WO2008046911
 US20060788995
 US20060838710
 WO2006DK00615
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.